Detalles de la búsqueda
1.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527425
2.
Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study.
HIV Clin Trials
; 17(1): 29-37, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26899540
3.
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment.
AIDS Care
; 28(3): 401-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26489045
4.
Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimens.
HIV Clin Trials
; 14(5): 216-23, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24144898
5.
Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
J Acquir Immune Defic Syndr
; 88(4): 393-398, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34506342
6.
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial.
Infect Dis Ther
; 10(2): 775-788, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33686573
7.
Formulation preference, tolerability and quality of life assessment following a switch from lopinavir/ritonavir soft gel capsule to tablet in human immunodeficiency virus-infected patients.
AIDS Res Ther
; 6: 29, 2009 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-20028544
8.
Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen.
AIDS
; 33(10): 1583-1593, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31305329
9.
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules.
AIDS Res Ther
; 5: 21, 2008 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-18799008
10.
Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy.
J Clin Pharmacol
; 47(8): 970-7, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17615254
11.
Antiretroviral pharmacokinetic profile: a review of sex differences.
Gend Med
; 4(2): 106-19, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17707845
12.
Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide.
Pharmacol Res Perspect
; 5(5)2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971607
13.
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.
AIDS
; 30(2): 251-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26684822
14.
Collaborative drug therapy management by pharmacists--2003.
Pharmacotherapy
; 23(9): 1210-25, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14524655
15.
Management of protease inhibitor-associated hyperlipidemia.
Am J Cardiovasc Drugs
; 2(2): 91-106, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-14727985
16.
Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia.
Expert Opin Drug Saf
; 1(1): 5-17, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12904155
17.
Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis.
AIDS Patient Care STDS
; 28(4): 168-75, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24660840
18.
Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.
AIDS
; 28(7): 989-97, 2014 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508782
Resultados
1 -
18
de 18
1
Próxima >
>>